Pancreas News and Research

RSS
The pancreas is a gland organ in the digestive and endocrine system of vertebrates. It is both an endocrine gland producing several important hormones, including insulin, glucagon, and somatostatin, as well as an exocrine gland, secreting pancreatic juice containing digestive enzymes that pass to the small intestine. These enzymes help in the further breakdown of the carbohydrates, protein, and fat in the chyme.
New approaches to regenerate insulin-producing cells for type I diabetes

New approaches to regenerate insulin-producing cells for type I diabetes

Study suggests amylin deposits are a new biomarker for age-related dementia and Alzheimer's

Study suggests amylin deposits are a new biomarker for age-related dementia and Alzheimer's

Curing type 1 diabetes: an interview with Dr. Habib Zaghouani, MU School of Medicine

Curing type 1 diabetes: an interview with Dr. Habib Zaghouani, MU School of Medicine

Study: More people are being affected by drug-induced liver injury than ever before

Study: More people are being affected by drug-induced liver injury than ever before

UCI researchers receive $2.27M to develop innovative methods of treating Type 1 diabetes.

UCI researchers receive $2.27M to develop innovative methods of treating Type 1 diabetes.

Promising approach to reduce risk of hypoglycemia in diabetes shows positive results

Promising approach to reduce risk of hypoglycemia in diabetes shows positive results

Sanofi reports Phase 3 study of insulin U300 shows better blood sugar control than Lantus

Sanofi reports Phase 3 study of insulin U300 shows better blood sugar control than Lantus

Linagliptin significantly reduces blood glucose levels in T2D patients with moderate to severe renal impairment

Linagliptin significantly reduces blood glucose levels in T2D patients with moderate to severe renal impairment

Scientists use stem-cell technology to create research cell line from PDAC patient

Scientists use stem-cell technology to create research cell line from PDAC patient

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Study: Multiple islet autoantibodies in children indicate risk of developing type 1 diabetes

Study: Multiple islet autoantibodies in children indicate risk of developing type 1 diabetes

TEDDY study enables scientists to parse genetic mutations associated with type 1 diabetes

TEDDY study enables scientists to parse genetic mutations associated with type 1 diabetes

15 minute walk after each meal appears to reduce risk of type 2 diabetes

15 minute walk after each meal appears to reduce risk of type 2 diabetes

Countrywide study in Germany deems PRRT as life-prolonging treatment for patients with NETs

Countrywide study in Germany deems PRRT as life-prolonging treatment for patients with NETs

Clinical trial underway for potential new treatment for type 1 diabetes

Clinical trial underway for potential new treatment for type 1 diabetes

Cedars-Sinai opens Phase III clinical trial for patients with intestinal carcinoid cancer

Cedars-Sinai opens Phase III clinical trial for patients with intestinal carcinoid cancer

Rewinding the developmental state of embryonic stem cells is possible, say researchers

Rewinding the developmental state of embryonic stem cells is possible, say researchers

Stem cells that strongly express WNT3 are biased to develop into cells and tissues, say researchers

Stem cells that strongly express WNT3 are biased to develop into cells and tissues, say researchers

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

CREON Delayed-Release Capsules now available in US for patients with EPI

CREON Delayed-Release Capsules now available in US for patients with EPI

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.